- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03026647
Suture Material for Closure of Hysterotomy
November 8, 2017 updated by: Jennifer Goldkamp, MD, St. Louis University
Evaluation of Suture Material for Closure of Hysterotomy
Retrospective chart review evaluating different suture types on surgical outcomes for cesarean delivery and vaginal birth after cesarean delivery outcomes when different sutures are used.
Study Overview
Status
Withdrawn
Intervention / Treatment
Detailed Description
Cesarean sections are one of the most common surgeries performed in the United States; approximately 1 out of 3 births are completed by cesarean delivery.
In 2014, 1,284,551 cesarean deliveries were performed.
Unfortunately, even with this being a very common procedure some surgical topics have not been fully evaluated.
One of these topics is the choice of suture for repair of the hysterotomy (uterine) incision.
Several suture materials are available, yet only polygatactin-910 and catgut have been evaluated in a single study.
In this study, only surgery complications were evaluated.
Catgut was found to be associated with less risk of receiving a blood transfusion, otherwise no differences were found.
One of the most common suture materials used at our institution is poliglecaprone 25, however no long term studies have been completed for this indication.
In addition, no studies have evaluated the risk of uterine rupture with trial of labor after cesarean after using poliglecaprone 25 to repair the hysterotomy.
This information could be very useful in counseling for patients.
As the cesarean delivery rates continue to climb, information on appropriate technique for surgery are needed.
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63117
- St. Mary's Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 55 years (ADULT, CHILD)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Female, pregnant, All ethnic backgrounds,
Description
Inclusion Criteria:
- Pregnant women who underwent a cesarean delivery or vaginal birth after cesarean
Exclusion Criteria:
- unable to give consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preferred suture
Time Frame: 3 months
|
Preferred suture chart review
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 31, 2017
Primary Completion (ANTICIPATED)
April 1, 2018
Study Completion (ANTICIPATED)
May 1, 2018
Study Registration Dates
First Submitted
January 18, 2017
First Submitted That Met QC Criteria
January 18, 2017
First Posted (ESTIMATE)
January 20, 2017
Study Record Updates
Last Update Posted (ACTUAL)
November 13, 2017
Last Update Submitted That Met QC Criteria
November 8, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27509
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section; Complications, Wound, Hematoma
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section; Complications, Wound, HematomaTurkey
-
Riphah International UniversityCompletedCesarean Section; Complications, Wound, HematomaPakistan
-
Odense University HospitalHvidovre University Hospital; Smith & Nephew, Inc.; University of Southern Denmark and other collaboratorsCompletedSurgical Wound Infection | Cesarean Section; Dehiscence | Complications; Cesarean Section | Infection; Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence | Wound; Rupture, Surgery, Cesarean SectionDenmark
-
Odense University HospitalHvidovre University Hospital; Smith & Nephew, Inc.; University of Southern Denmark and other collaboratorsCompletedSurgical Wound Infection | Cesarean Section; Dehiscence | Complications; Cesarean Section | Infection; Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence | Wound; Rupture, Surgery, Cesarean SectionDenmark
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Uludag UniversityUnknownCesarean Section Complications | Cesarean Wound Disruption | Cesarean Wound; DehiscenceTurkey
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedCesarean Section Complications | Cesarean Wound; DehiscenceItaly
-
Loyola UniversityMolnlycke Health Care ABCompletedCesarean Section; Complications, Wound, DehiscenceUnited States
-
Studio Osteopatico Busto ArsizioSuspendedCesarean Section Complications | Cesarean Section; Complications, Wound, Infection (Following Delivery)Italy
-
Columbia UniversityCompletedCesarean Section | Complication | WoundUnited States
Clinical Trials on Suture
-
Montefiore Medical CenterCompletedSurgical Wound Infection | Complications; Cesarean SectionUnited States
-
Hadassah Medical OrganizationUnknownOral Surgical Procedures
-
Tianjin Eye HospitalRecruitingPrimary PterygiumChina
-
Stanford UniversityTerminatedNasal Obstruction | Nasal Septum; Deviation, CongenitalUnited States
-
Sun Yat-sen UniversityCompletedSurgery--Complications | Retinoblastoma Bilateral
-
Instituto Mexicano del Seguro SocialCompletedOrbital Floor Fractures | Surgical Wound Closure Techniques | Subciliary Surgical Approach | Postoperative Complications in Maxillofacial SurgeryMexico
-
Yuzuncu Yıl UniversityCompletedImpacted Third Molar ToothTurkey
-
Bezmialem Vakif UniversityCompletedCesarean Section Complications | Wound Heal | Suture Related Complication | Cesarean Wound DisruptionTurkey
-
Barzilai Medical CenterCompletedCesarean SectionIsrael
-
Rutgers UniversityCompleted